US Stock MarketDetailed Quotes

BEAM Beam Therapeutics

Watchlist
  • 25.460
  • -1.470-5.46%
Close Jul 18 16:00 ET
  • 25.500
  • +0.040+0.16%
Post 17:34 ET
2.10BMarket Cap-15912P/E (TTM)

Beam Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
9.17%-99.75M
-762.29%-149.2M
295.22%135.07M
-20.52%-89.78M
-61.97%-84.67M
-150.26%-109.82M
133.99%22.53M
-3,880.93%-69.19M
-2,577.42%-74.5M
-60.72%-52.28M
Net income from continuing operations
-2.29%-98.67M
54.16%-132.53M
472.36%142.8M
12.31%-96.09M
-15.05%-82.78M
-39.36%-96.46M
22.00%-289.09M
40.73%-38.35M
-289.70%-109.58M
5.64%-71.95M
Operating gains losses
151.79%2.9M
-568.75%-7.5M
163.33%1.9M
-115.46%-4.7M
107.38%900K
58.82%-5.6M
60.00%1.6M
59.46%-3M
184.92%30.4M
-128.84%-12.2M
Depreciation and amortization
16.87%5.43M
41.46%20.01M
35.95%5.36M
49.35%5.19M
40.90%4.82M
40.31%4.65M
89.87%14.15M
49.73%3.94M
98.46%3.47M
104.79%3.42M
Other non cash items
-5.89%2.49M
97.89%-221K
103.12%539K
-223.06%-3.71M
-86.29%304K
71.19%2.65M
-106.59%-10.47M
-360.79%-17.25M
135.71%3.02M
-26.49%2.22M
Change In working capital
15.33%-37.96M
-146.28%-116.46M
-204.42%-31.51M
-89.35%-19.64M
-1,753.47%-20.47M
-116.54%-44.83M
126.17%251.63M
-123.02%-10.35M
-118.59%-10.37M
-89.79%1.24M
-Change in receivables
----
-100.05%-146K
---146K
--0
----
----
200.00%300M
--0
--0
--0
-Change in prepaid assets
34.18%-5.53M
16.51%-6.47M
736.36%3.57M
-1,417.87%-3.57M
-13.42%1.93M
8.49%-8.41M
-1,139.28%-7.75M
-4,415.38%-561K
-106.12%-235K
400.67%2.23M
-Change in payables and accrued expense
-127.20%-22.99M
512.67%60.09M
505.07%68.63M
-4.17%4.37M
77.92%-2.8M
43.10%-10.12M
-132.55%-14.56M
-73.78%11.34M
926.27%4.56M
-277.25%-12.68M
-Change in other current assets
----
--0
----
----
----
----
--0
----
----
----
-Change in other current liabilities
2.81%-2.53M
-205.08%-10.36M
-267.15%-4.02M
-395.73%-3.25M
-114.46%-483K
-139.93%-2.6M
-44.65%9.86M
-139.68%-1.1M
-66.35%1.1M
-41.65%3.34M
-Change in other working capital
70.85%-6.91M
-344.21%-159.56M
-396.80%-99.54M
-8.82%-17.19M
-328.99%-19.12M
-181.17%-23.71M
-110.32%-35.92M
-106.70%-20.04M
-1,967.93%-15.8M
-83.30%8.35M
Cash from discontinued investing activities
Operating cash flow
9.17%-99.75M
-762.29%-149.2M
295.22%135.07M
-20.52%-89.78M
-61.97%-84.67M
-150.26%-109.82M
133.99%22.53M
-3,880.93%-69.19M
-2,577.42%-74.5M
-60.72%-52.28M
Investing cash flow
Cash flow from continuing investing activities
-310.07%-53.46M
115.57%71.84M
-13.52%98.1M
71.72%-10.23M
-3,186.85%-41.48M
104.74%25.45M
-56.84%-461.34M
246.38%113.44M
-147.53%-36.17M
90.39%-1.26M
Net PPE purchase and sale
59.48%-2.44M
31.09%-33.73M
56.55%-3.59M
32.57%-7.95M
25.25%-16.18M
17.11%-6.02M
-4.57%-48.95M
38.21%-8.26M
-103.93%-11.79M
-33.74%-21.64M
Net business purchase and sale
----
--0
----
----
----
----
--0
----
----
----
Net investment purchase and sale
-262.15%-51.03M
125.60%105.57M
-16.44%101.69M
90.64%-2.28M
-224.14%-25.3M
105.94%31.47M
-66.32%-412.39M
289.78%121.7M
-129.78%-24.39M
568.92%20.38M
Cash from discontinued investing activities
Investing cash flow
-310.07%-53.46M
115.57%71.84M
-13.52%98.1M
71.72%-10.23M
-3,186.85%-41.48M
104.74%25.45M
-56.84%-461.34M
246.38%113.44M
-147.53%-36.17M
90.39%-1.26M
Financing cash flow
Cash flow from continuing financing activities
-97.06%2.9M
147.74%276.45M
5.31%33.71M
2,254.48%36.78M
381.39%107.54M
76.77%98.42M
-85.24%111.59M
48.60%32.01M
-99.51%1.56M
-86.08%22.34M
Net issuance payments of debt
70.65%-177K
1.53%-2.25M
-7.12%-632K
30.92%-400K
-9.20%-617K
-9.04%-603K
-7.98%-2.29M
-8.86%-590K
-9.25%-579K
-9.28%-565K
Net common stock issuance
--0
149.56%270.17M
5.35%33.6M
--34.95M
381.36%107.64M
74.03%93.98M
-85.71%108.26M
57.54%31.89M
--0
-85.87%22.36M
Proceeds from stock option exercised by employees
-39.73%3.07M
57.79%9.16M
-2.36%745K
20.78%2.62M
8.67%702K
128.49%5.1M
-39.67%5.81M
-61.25%763K
-19.84%2.17M
-79.79%646K
Net other financing activities
----
-235.64%-631K
--0
-1,436.00%-384K
-79.61%-185K
-933.33%-62K
97.87%-188K
57.81%-54K
88.04%-25K
80.34%-103K
Cash from discontinued financing activities
Financing cash flow
-97.06%2.9M
147.74%276.45M
5.31%33.71M
2,254.48%36.78M
381.39%107.54M
76.77%98.42M
-85.24%111.59M
48.60%32.01M
-99.51%1.56M
-86.08%22.34M
Net cash flow
Beginning cash position
81.09%444.61M
-57.13%245.52M
5.00%177.73M
-13.44%240.97M
-16.15%259.57M
-57.13%245.52M
223.56%572.74M
-73.00%169.26M
22.71%278.37M
176.20%309.57M
Current changes in cash
-1,169.70%-150.31M
160.84%199.09M
249.97%266.89M
42.04%-63.24M
40.36%-18.61M
105.34%14.05M
-182.69%-327.22M
240.90%76.26M
-127.28%-109.11M
-127.18%-31.2M
End cash Position
13.38%294.3M
81.09%444.61M
81.09%444.61M
5.00%177.73M
-13.44%240.97M
-16.15%259.57M
-57.13%245.52M
-57.13%245.52M
-73.00%169.26M
22.71%278.37M
Free cash flow
11.78%-102.19M
-592.28%-182.93M
269.76%131.48M
-13.27%-97.73M
-36.43%-100.85M
-154.84%-115.83M
76.63%-26.42M
-571.22%-77.45M
-3,011.54%-86.28M
-51.75%-73.92M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 9.17%-99.75M-762.29%-149.2M295.22%135.07M-20.52%-89.78M-61.97%-84.67M-150.26%-109.82M133.99%22.53M-3,880.93%-69.19M-2,577.42%-74.5M-60.72%-52.28M
Net income from continuing operations -2.29%-98.67M54.16%-132.53M472.36%142.8M12.31%-96.09M-15.05%-82.78M-39.36%-96.46M22.00%-289.09M40.73%-38.35M-289.70%-109.58M5.64%-71.95M
Operating gains losses 151.79%2.9M-568.75%-7.5M163.33%1.9M-115.46%-4.7M107.38%900K58.82%-5.6M60.00%1.6M59.46%-3M184.92%30.4M-128.84%-12.2M
Depreciation and amortization 16.87%5.43M41.46%20.01M35.95%5.36M49.35%5.19M40.90%4.82M40.31%4.65M89.87%14.15M49.73%3.94M98.46%3.47M104.79%3.42M
Other non cash items -5.89%2.49M97.89%-221K103.12%539K-223.06%-3.71M-86.29%304K71.19%2.65M-106.59%-10.47M-360.79%-17.25M135.71%3.02M-26.49%2.22M
Change In working capital 15.33%-37.96M-146.28%-116.46M-204.42%-31.51M-89.35%-19.64M-1,753.47%-20.47M-116.54%-44.83M126.17%251.63M-123.02%-10.35M-118.59%-10.37M-89.79%1.24M
-Change in receivables -----100.05%-146K---146K--0--------200.00%300M--0--0--0
-Change in prepaid assets 34.18%-5.53M16.51%-6.47M736.36%3.57M-1,417.87%-3.57M-13.42%1.93M8.49%-8.41M-1,139.28%-7.75M-4,415.38%-561K-106.12%-235K400.67%2.23M
-Change in payables and accrued expense -127.20%-22.99M512.67%60.09M505.07%68.63M-4.17%4.37M77.92%-2.8M43.10%-10.12M-132.55%-14.56M-73.78%11.34M926.27%4.56M-277.25%-12.68M
-Change in other current assets ------0------------------0------------
-Change in other current liabilities 2.81%-2.53M-205.08%-10.36M-267.15%-4.02M-395.73%-3.25M-114.46%-483K-139.93%-2.6M-44.65%9.86M-139.68%-1.1M-66.35%1.1M-41.65%3.34M
-Change in other working capital 70.85%-6.91M-344.21%-159.56M-396.80%-99.54M-8.82%-17.19M-328.99%-19.12M-181.17%-23.71M-110.32%-35.92M-106.70%-20.04M-1,967.93%-15.8M-83.30%8.35M
Cash from discontinued investing activities
Operating cash flow 9.17%-99.75M-762.29%-149.2M295.22%135.07M-20.52%-89.78M-61.97%-84.67M-150.26%-109.82M133.99%22.53M-3,880.93%-69.19M-2,577.42%-74.5M-60.72%-52.28M
Investing cash flow
Cash flow from continuing investing activities -310.07%-53.46M115.57%71.84M-13.52%98.1M71.72%-10.23M-3,186.85%-41.48M104.74%25.45M-56.84%-461.34M246.38%113.44M-147.53%-36.17M90.39%-1.26M
Net PPE purchase and sale 59.48%-2.44M31.09%-33.73M56.55%-3.59M32.57%-7.95M25.25%-16.18M17.11%-6.02M-4.57%-48.95M38.21%-8.26M-103.93%-11.79M-33.74%-21.64M
Net business purchase and sale ------0------------------0------------
Net investment purchase and sale -262.15%-51.03M125.60%105.57M-16.44%101.69M90.64%-2.28M-224.14%-25.3M105.94%31.47M-66.32%-412.39M289.78%121.7M-129.78%-24.39M568.92%20.38M
Cash from discontinued investing activities
Investing cash flow -310.07%-53.46M115.57%71.84M-13.52%98.1M71.72%-10.23M-3,186.85%-41.48M104.74%25.45M-56.84%-461.34M246.38%113.44M-147.53%-36.17M90.39%-1.26M
Financing cash flow
Cash flow from continuing financing activities -97.06%2.9M147.74%276.45M5.31%33.71M2,254.48%36.78M381.39%107.54M76.77%98.42M-85.24%111.59M48.60%32.01M-99.51%1.56M-86.08%22.34M
Net issuance payments of debt 70.65%-177K1.53%-2.25M-7.12%-632K30.92%-400K-9.20%-617K-9.04%-603K-7.98%-2.29M-8.86%-590K-9.25%-579K-9.28%-565K
Net common stock issuance --0149.56%270.17M5.35%33.6M--34.95M381.36%107.64M74.03%93.98M-85.71%108.26M57.54%31.89M--0-85.87%22.36M
Proceeds from stock option exercised by employees -39.73%3.07M57.79%9.16M-2.36%745K20.78%2.62M8.67%702K128.49%5.1M-39.67%5.81M-61.25%763K-19.84%2.17M-79.79%646K
Net other financing activities -----235.64%-631K--0-1,436.00%-384K-79.61%-185K-933.33%-62K97.87%-188K57.81%-54K88.04%-25K80.34%-103K
Cash from discontinued financing activities
Financing cash flow -97.06%2.9M147.74%276.45M5.31%33.71M2,254.48%36.78M381.39%107.54M76.77%98.42M-85.24%111.59M48.60%32.01M-99.51%1.56M-86.08%22.34M
Net cash flow
Beginning cash position 81.09%444.61M-57.13%245.52M5.00%177.73M-13.44%240.97M-16.15%259.57M-57.13%245.52M223.56%572.74M-73.00%169.26M22.71%278.37M176.20%309.57M
Current changes in cash -1,169.70%-150.31M160.84%199.09M249.97%266.89M42.04%-63.24M40.36%-18.61M105.34%14.05M-182.69%-327.22M240.90%76.26M-127.28%-109.11M-127.18%-31.2M
End cash Position 13.38%294.3M81.09%444.61M81.09%444.61M5.00%177.73M-13.44%240.97M-16.15%259.57M-57.13%245.52M-57.13%245.52M-73.00%169.26M22.71%278.37M
Free cash flow 11.78%-102.19M-592.28%-182.93M269.76%131.48M-13.27%-97.73M-36.43%-100.85M-154.84%-115.83M76.63%-26.42M-571.22%-77.45M-3,011.54%-86.28M-51.75%-73.92M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Gene Editing
Gene Editing
Intraday-0.76%
ARK Holdings
ARK Holdings
Intraday-0.79%